initial public offerings (IPOs) trading on American exchanges

Thursday, January 23, 2014

BioAmber Inc. (BIOA) began trading on the NYSE on 10 June 2013

BioAmber Inc., a bio-based chemicals company, produces and sells bio-succinic acid in the United States. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into chemicals that are replacements for petroleum-derived chemicals. The company also has additional bio-based products under development with partners, which include bio-succinic acid derivatives, such as 1, 4 butanediol, gamma-butyrolactone, and succinic acid based polyesters. Its bio-succinic acid has applications in plasticizers, polyurethanes, personal care products, resins and coatings, food additives, lubricants, fine chemicals, and de-iciing solutions, as well as in other products that include anti-freeze solutions, solvents, water treatment chemicals, and effervescence agents, such as laundry tablets and bath salts. The company serves various chemical markets, such as polyurethanes, plasticizers, personal care products, de-icing solutions, resins and coatings, food additives, and lubricants. BioAmber Inc. sells its products directly to its customers, as well as indirectly through an exclusive distributor in the Asia-Pacific region. It has strategic relationships with Mitsui & Co., Ltd.; Mitsubishi Chemical Corporation; Lanxess Deutschland GmbH; Faurecia, S.A.; NatureWorks LLC; DuPont; Evonik Industries AG; Agro-industrie Recherches et Dveloppements; and Celexion, LLC. The company was formerly known as DNP Green Technology, Inc. and changed its name to BioAmber Inc. in 2010. BioAmber Inc. is headquartered in Montreal, Canada.

No comments:

Post a Comment